Literature DB >> 9582137

Management of hyperlipidaemia after coronary revascularisation: follow up study.

E Delacrétaz1, P G Michalopoulos, J Ruiz, H Saner, B Meier.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9582137      PMCID： PMC28551          DOI： 10.1136/bmj.316.7143.1499

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Current status of cholesterol treatment in the community: the Minnesota Heart Survey.

Authors:  R V Luepker
Journal:  Am J Med       Date:  1997-02-17       Impact factor: 4.965

2.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

Review 3.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

4.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

Review 5.  Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Authors:  B G Brown; X Q Zhao; D E Sacco; J J Albers
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690
  5 in total
  1 in total

1.  Poor compliance: the hidden risk factor.

Authors:  J C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.